key: cord-0253242-kjgmtlv0
authors: Van Leuven, James T.; Gonzalez, Andres J.; Wixom, Alexander Q.; Clary, John L.; Ridenhour, Benjamin J.; Miller, Craig R.; Miura, Tanya A.
title: Rhinovirus reduces the severity of subsequent respiratory viral infections, which is associated with dampened inflammatory responses
date: 2020-11-06
journal: bioRxiv
DOI: 10.1101/2020.11.06.371005
sha: 1bbb393c94dc6165d7a75101ba740b5a47fd9dde
doc_id: 253242
cord_uid: kjgmtlv0

Coinfection by unrelated viruses in the respiratory tract is common and can result in changes in disease severity compared to infection by individual virus strains. We have previously shown that inoculation of mice with rhinovirus (RV) two days prior to inoculation with a lethal dose of influenza A virus (PR8), provides complete protection against mortality. In this study, we extend that finding to a second lethal respiratory virus, pneumonia virus of mice (PVM) and characterize the differences in inflammatory responses and host gene expression in single virus infected vs. coinfected mice. RV prevented mortality and weight loss associated with PVM infection, suggesting that RV-mediated protection is more effective against PVM than PR8. Major changes in host gene expression upon PVM infection were delayed compared to PR8, which likely provides a larger time frame for RV-induced gene expression to alter the course of disease. Overall, RV induced earlier recruitment of inflammatory cells, while these populations were reduced at later times in coinfected mice. Findings common to both coinfection conditions included upregulated expression of mucin-associated genes in RV/PR8 and RV/PVM compared to mock/PR8 and mock/PVM infected mice and dampening of inflammation-related genes late during coinfection. These findings, combined with differences in virus replication levels and disease severity, suggest that the suppression of inflammation in RV/PVM coinfected mice may be due to early suppression of viral replication, while in RV/PR8 coinfected mice may be due to a direct suppression of inflammation. Thus, a mild upper respiratory viral infection can reduce the severity of a subsequent severe viral infection in the lungs through virus-dependent mechanisms. Author Summary Respiratory viruses from diverse families co-circulate in human populations and are frequently detected within the same host. Though clinical studies suggest that coinfection by more than one unrelated respiratory virus may alter disease severity, animal models in which we can control the doses, timing, and strains of coinfecting viruses are critical to understand how coinfection affects disease severity. In this study, we compared gene expression and immune cell recruitment between two pairs of coinfecting viruses (RV/PR8 and RV/PVM) that both result in reduced severity compared to infection by PR8 or PVM alone in mice. Reduced disease severity was associated with suppression of inflammatory responses in the lungs. However, differences in disease kinetics and host and viral gene expression suggest that protection by coinfection with RV may be due to distinct molecular mechanisms.

The detection of more than one virus in respiratory samples is quite common, especially 52 among pediatric patients (1-4). There are differences in the outcomes of coinfection -whether it 53 results in increased, decreased, or no effect on disease severity -that likely reflect different virus 54 parings, patient populations, and study criteria. For example, coinfection with influenza B virus 124 Infection by PR8 and PVM induce different gene expression signatures in mouse lungs over 125 time 126 127

To determine potential mechanisms of protection mediated by RV against PR8 and PVM, 128 we undertook a comprehensive transcriptome analysis of mouse lungs (Fig 2) . Mice were 129 coinfected with RV two days before PR8 or PVM and total lung RNA was analyzed on days 0, 2, 130 4, and 6 after PR8 or PVM inoculation. Single virus-infected mice were mock-inoculated two days 131 before PR8 or PVM and total lung RNA was isolated at the same time points. Weight loss was 132 monitored daily to test for consistency with our previous morbidity and mortality analyses. RV-133 mediated protection against PR8 was not evident by 6 days post-infection (S1 Fig) though both 134 mock/PR8 and RV/PR8 groups experienced weight loss at a rate similar to our previous study (9).

135 In contrast, complete protection against weight loss was evident in RV/PVM coinfected mice (S1 136 Fig) . 

Many reads mapped to PR8 and PVM genomes from the mice infected with these viruses 187 (Fig 4) . Coinfection by RV did not prevent PR8-specific gene expression, but reads mapped to 188 PR8 were significantly lower in coinfected mice at all time points (Fig 4) . Similarly, we previously 189 showed that infectious PR8 titers in the lungs were equivalent in mock/PR8 and RV/PR8 infected 190 mice on days 2 and 4 after PR8 inoculation (9). However, coinfection with RV led to earlier 

The proportions of neutrophils and interstitial macrophages followed the same trends as 295 total CD11b+ cells in PVM-infected mice, with lower proportions of these cells on days 4 and 6 296 in coinfected mice (Fig 7F, 7G ). In contrast, interstitial macrophages were increased in RV/PVM, 297 compared to mock/PVM-infected mice, early in infection. This indicates that coinfection by RV 298 stimulates early recruitment of CD11b+ cells, specifically interstitial macrophages, while limiting 299 recruitment of inflammatory cells later in infection. PR8-infected mice had similar trends, however 300 the differences between mock/PR8 and RV/PR8 groups were less dramatic (Fig 7B, 7C ).

301 Neutrophil numbers were suppressed in RV/PR8 coinfected mice compared to mock/PR8 infected 302 mice through-out the time course (Fig 7b) . The interstitial macrophage proportions in mock/PR8-303 and RV/PR8-infected mice increased over time similarly to the total CD11b+ populations (Fig   304 7C) . The lower proportions of neutrophils and interstitial macrophages at later time points in RV-305 coinfected mice corresponded with mRNA levels for chemokines. This was predominantly the 306 case for neutrophil chemokines Cxcl1 and Cxcl2 (Fig 7I, 7K ) and macrophage chemokines Ccl2 307 and Ccl7 (Fig 7J, 7L) . These chemokines were generally lower in RV/PR8 coinfected mice on day 308 6 and RV/PVM coinfected mice on days 4 and 6 compared to mock/PR8 and mock/PVM infected 309 mice, respectively.

There were no clear trends in alveolar macrophage numbers in mock/PR8-and RV/PR8-311 infected mice (Fig 7D) , though their proportions were significantly higher in RV/PVM-coinfected 312 mice compared to mock/PVM-infected mice on days 4 and 6 ( Fig 7H) . This is likely due to Discussion 320 Previously, we found that inoculation of mice with a mild respiratory viral pathogen, RV 321 or murine coronavirus MHV-1, two days before PR8 provided significant protection against PR8-322 mediated disease (9). In this study, we expanded these results to show that RV-mediated protection 323 was not specific to PR8, but also provided significant disease protection against a respiratory virus 324 from another viral family, PVM. This is in agreement with other studies showing protection 325 afforded by viral coinfection (10-12). Despite the commonality of coinfection resulting in reduced 326 disease severity, there are differences between the virus combinations in the kinetics of disease 327 and viral replication. Coinfection by RV provided more effective protection against PVM than 328 PR8. RV/PVM coinfected mice had little to no signs of disease (Fig 1) and significantly limited 329 PVM replication (Fig 4) . In contrast, coinfection by RV prevented mortality, but not morbidity, 330 associated with PR8 infection, and reduced viral gene expression but did not prevent infection by 331 PR8 (Fig 4) (9) . Further, RV given concurrently with PVM was as effective as when it was given 332 two days before PVM (Fig 1) . In contrast, RV was less effective at reducing the severity of PR8 333 when given concurrently and also exacerbated disease when it was given two days after PR8 (9). 334 We also observed differences in the kinetics of gene expression in response to these virus pairs.

335 Host (Fig 3) and viral (Fig 4) gene expression changes in response to PVM were delayed compared 336 to PR8, thereby giving a larger window for RV-mediated protection. Thus, RV may be inducing 337 antiviral mechanisms that are more effective against PVM, or different mechanisms may be 338 responsible for inhibiting PVM infection and mediating effective clearance of PR8. We used 339 transcriptomic and flow cytometry analyses to identify potential mechanisms that mediate 340 protection against PR8 and PVM in mice that were coinfected with RV.

Analysis of RV-inoculated mice on day 0 (two days after RV inoculation) revealed up-342 regulation of 327 genes. These genes were highly enriched in GO categories that involved cell 343 division or chemokine signaling (S2 Table) . Despite expression of several chemokine and 344 chemokine receptor genes, we did not observe a dramatic increase in immune cells in the lungs of 345 RV-infected mice on day 0 (Fig 7) . Although our flow cytometry results had variability in RV-346 infected mice on day 0 between our studies, we detected a significant increase in interstitial 347 macrophages in the RV/PVM study (Fig 7G 

In contrast to early recruitment of neutrophils, RV-coinfected mice had reduced numbers 357 of neutrophils and interstitial macrophages later during infection (Fig 7) . This decrease in 358 inflammatory cell recruitment could be a result of reduced viral infection (Fig 4) and We analyzed flow cytometry (Fig 7) and viral read count (Fig 4) data resulting from our 508 experiments to identify time-varying differences between mice infected with PR8 or PVM alone 509 or coinfected with RV. To this end, we used negative binomial regression on each response 510 variable with an explanatory model that had a main effect of days post-infections, a main effect of 511 treatment (single or coinfection), and the interaction between the two main effects. Response 512 variables were the number of CD11b cells, neutrophils, interstitial macrophages, alveolar 513 macrophages, and viral read counts; all response variables were normalized versus total cell count 514 except for viral RNA read count which was normalized against total RNA read count. Due to a 515 prior visual investigation of our data, it seemed some of our response variables might be better fit 516 with a quadratic time term. Because of this we fit an alternative model that included an orthogonal 517 polynomial of degree 2 for time. We assessed whether the quadratic model was better than the 518 linear model using a likelihood ratio test and chose the quadratic model if it offered a significant 519 improvement in fit over the simpler linear model. The significance of treatment and time was 520 determined using a type-I ANOVA. To detect differences between treatments at a given time, we 521 also performed post hoc pairwise comparisons of the modeled mean at our observational time 522 points (days 0, 2, 4, and 6) using the emmeans package in R. Supplemental Table 3 

clustering closely with mock and RV day 0 samples, respectively (Fig 3A, blue and purple points)

In contrast, PR8 infection dramatically altered gene expression in mice by day 2 (Fig 3A, 153 light green points). Early changes in host gene expression induced by PR8, but not PVM, 154 corresponded with earlier detection of PR8-specific transcripts (Fig 4). Moreover, the RV/PVM 155 and mock/PVM samples were very different from each other

Despite dramatic differences in infection outcomes, RV/PR8 and mock/PR8 groups had similar 157 gene expression signatures until day 6 (Fig 3A, orange points)

As reflected in the PCA, gene expression changed 162 over time, as samples taken 2 days post-infection were most similar to mock-inoculated controls 163 and samples taken 6 days post-infection were most different (Fig 3B, 3C). The transition of point 164 clustering in Fig 3B from around the origin at day 2 to spread along the 1:1 line on day 6 illustrates 165 this delayed gene expression response to viral infection. Genes differentially expressed between 166 single virus-infected and coinfected mice also displayed time-dependent clustering shifts in both 167 the PVM and PR8 experiments (Fig 3B)

This 195 and not complementary (cRNA) or genomic (vRNA) viral RNAs. Based on individual gene 196 mapping, the PR8 reads predominantly mapped to the nucleoprotein (NP) and hemagglutinin (HA) 197 mRNAs (S2 Fig)

PVM gene expression was highest on day 4 and was robustly suppressed in RV-coinfected

This suggests that RV may limit PVM infection early

This does not 204 strictly follow the gradient of mRNA levels corresponding with gene order that is expected from 205 pneumoviruses (41), which likely reflects post-transcriptional differences in mRNA stability and 206 the heterogeneous nature of collecting cells at different stages of the virus replication cycle

Up-regulation of cell division-associated genes could be occurring in epithelial cells 218 in conjunction with repair, immune cells recruited to the lungs, or both. In addition to cell division, 219 multiple immune response-related GO terms related to type I IFN signaling, chemokine signaling, 220 and immune cell chemotaxis were enriched by RV infection (S2 Table). RV infection induced up-221 regulation of several chemokine genes

Host gene expression changes associated with viral coinfection 225 We next identified DEGs specific to coinfected (RV/PR8 or RV/PVM) vs. mock

Genes with increased up-regulation in mice infected 232 with RV/PVM compared to mock/PVM early (days 2 and 4) included Mgl2, Ccl6, Agr2, H2-M2, 233 and Muc5b. Genes that had higher up-regulation in the single virus infections were predominantly 234 increased late (days 4 and/or 6) and included genes associated with inflammation (Angptl4) or 235 pulmonary fibrosis (Fosl2, Pappa, Sphk1)

In contrast to upregulating expression of 402 genes associated with mucin production and goblet cell metaplasia, FoxA3 suppresses genes 403 involved in antiviral innate immune responses (54)

Additionally, this inhibitory role may contribute to down-regulation of detrimental 406 inflammatory responses during coinfection. In addition to up-regulation of mucin genes, other 407 genes important to mucin production and hydration had increased RNA levels in coinfected mice

We found dramatic differences in the effects of interferon (IFN)-response genes in PR8 vs

Similarly, other studies have shown no induction of IFN signaling at 412 24 hours (20) vs. strong IFN signaling by 6 days (16) after PVM infection in mice, although these 413 studies used two different PVM strains in C57Bl/6 mice. In contrast, RV/PR8 coinfected mice had 414 early (day 2) up-regulation of IFN-response genes and later down-regulation (day 6)

Clinical signs in these four categories were pentobarbital followed by exsanguination when mice lost more than 25% of their starting 449 weight, exhibited severe clinical signs of disease, or at pre-determined time points. Survival and 450 weight loss data were analyzed with Prism 6.0 (Graphpad) software using Log-rank Mantel-Cox 451 and student's t-test corrected for multiple comparisons using the Holm-Sidak method, respectively. 452 RNA-seq and flow cytometry experiments were performed using groups of five mice

The three samples with the highest RNA quality from each group were 463 used for RNA-seq analysis. Stranded RNA libraries were prepared from 4 ug RNA of each sample 464 by UI's IBEST Genomics Resources Core according to KAPA's stranded mRNA-seq (KK8420) 465 library preparation protocol with capture of polyadenylated mRNAs. Libraries were tagged with 466 unique ligation adapters (BioOScientific), amplified, quantified (qubit and fragment analyzer), and 467 pooled at an equimolar ratio. The pooled library was split, pooled with other libraries, and 468 sequenced across 5 lanes of an Illumina HiSeq4000 100bp PE run at University of Oregon's 469 Genomics and Cell Characterization Core. Paired end reads (100 bp) were quality trimmed and 470 filtered using Trimmomatic v0

Reads that did not map to the mouse genome were extracted and de-interleaved using

BBmaps' reformat script

These reads were aligned to the RV1B (D00239), PR8 (LC120388-LC120395), and PVM

The DEG lists for each treatment comparison were searched for differentially enriched 487 gene ontologies (GO terms) and KEGG pathways using CompGO (65)

EdgeR, DESeq2) and combinations

Viruses in 540 community-acquired pneumonia in children aged less than 3 years old: High rate of viral 541 coinfection

Influenza A viruses dual and multiple infections 543 with other respiratory viruses and risk of hospitalisation and mortality. Influenza Other Respir 544 Viruses

Etiology 546 and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia

Clinical and CT features in pediatric patients 549 with COVID-19 infection: Different points from adults

Multiple versus single virus respiratory 551 infections: viral load and clinical disease severity in hospitalized children. Influenza and other 552 respiratory viruses

Rates of co-infection between SARS-CoV-2 554 and other respiratory pathogens

Coinfection with SARS-CoV-2 556 and other respiratory pathogens in patients with COVID-19 in Guangzhou

Co-infections in people with COVID-19: a 559 systematic review and meta-analysis

Attenuation of Influenza A Virus Disease 561 Severity by Viral Coinfection in a Mouse Model

Nasal 563 priming by a murine coronavirus provides protective immunity against lethal heterologous virus 564 pneumonia

Interval 566 Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following 567 Influenza Virus Infection in a Ferret Model

Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret 570 Model of Infection

Pneumonia Virus of Mice (PVM) model of acute respiratory infection

Animal pneumoviruses: molecular genetics 575 and pathogenesis

Neutrophilic 577 inflammation in the respiratory mucosa predisposes to RSV infection

Inflammatory 580 responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice

Animal model 583 of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by 584 sphingosine-1-phosphate 1 receptor agonist therapy

Type I interferon 586 signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice

Functional 589 Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue 590 Inflammation

Both 592 nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon 593 type I and type III responses in vivo

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against 596 hepatotropic viruses

Depletion of alveolar macrophages prolongs 598 survival in response to acute pneumovirus infection. Virology. 2011. 599 23. Cardani A

Influenza Pneumonia By Inhibiting Infection Of Type-1 Alveolar Epithelial Cells

Plasmacytoid dendritic 603 cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent 604 signaling pathway

Plasmacytoid 606 dendritic cells are dispensable during primary influenza virus infection

Critical Adverse 609 Impact of IL-6 in Acute Pneumovirus Infection

Early IL-6 signalling promotes IL-27

dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology

IL-6 ameliorates acute 614 lung injury in influenza virus infection

Intranasal treatment with a novel immunomodulator mediates innate immune protection against 617 lethal pneumonia virus of mice

mansoni bolsters 619 anti-viral immunity in the murine respiratory tract

Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs

Altered pathogenesis of severe 624 pneumovirus infection in response to combined antiviral and specific immunomodulatory agents

Functional 627 antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in 628 vivo

CCR2-antagonist prophylaxis 630 reduces pulmonary immune pathology and markedly improves survival during influenza infection

CXCL10-CXCR3 633 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral 634 origin

Deletion of 636 nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and 637 reduces pulmonary cytokine expression and disease

Mouse 639 models of rhinovirus-induced disease and exacerbation of allergic airway inflammation

Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes 643 infected with influenza A virus

Alteration 645 of protein levels during influenza virus H1N1 infection in host cells: a proteomic survey of host 646 and virus reveals differential dynamics

RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals 649 Splicing of Gene Segment 6 and Novel Host-Virus Interactions

Respiratory syncytial virus: virology, reverse genetics, 651 and pathogenesis of disease

Gene 653 set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression 654 profiles

Molecular Signatures Database (MSigDB) hallmark gene set collection

Flow cytometric 659 analysis of macrophages and dendritic cell subsets in the mouse lung

Unique Interstitial Macrophages in the Murine Lung at Steady State

Priming 665 of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar 666 Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM)

TLR2 Activation 669 Limits Rhinovirus-Stimulated CXCL-10 by Attenuating IRAK-1-Dependent IL-33 Receptor 670 Signaling in Human Bronchial Epithelial Cells

Rhinovirus 672 attenuates non-typeable Hemophilus influenzae-stimulated IL-8 responses via TLR2-dependent 673 degradation of IRAK-1

Rhinovirus exposure 675 impairs immune responses to bacterial products in human alveolar macrophages

A Decoy Peptide 678 that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza

The theta-defensin

retrocyclin 101 inhibits TLR4-and TLR2-dependent signaling and protects mice against influenza 682 infection

Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus 685 infection

Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory 688 virus infection

Foxa3 induces goblet 690 cell metaplasia and inhibits innate antiviral immunity

Rhinovirus-induced major airway mucin 693 production involves a novel TLR3-EGFR-dependent pathway

Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular 697 regulated kinase-Sp1-dependent pathway

Influenza promotes pneumococcal growth during 699 coinfection by providing host sialylated substrates as a nutrient source

Time-dependent airway epithelial and

Detrimental role of the airway mucin Muc5ac during ventilator-induced lung injury

Trimmomatic: a flexible trimmer for Illumina sequence 708 data

TopHat2: accurate 710 alignment of transcriptomes in the presence of insertions, deletions and gene fusions

Transcript 713 assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching 714 during cell differentiation

HTSeq-a Python framework to work with high-throughput 716 sequencing data

SARTools: A DESeq2-and EdgeR

CompGO: an R package for 720 comparing and visualizing Gene Ontology enrichment differences between DNA binding 721 experiments

Supplemental Table 1 provides raw read counts (mean of the three replicates and normalized to 726 library size) and log2 fold change values for genes that had statistically significant differences in 727 expression between each comparison (infected or coinfected vs. mock-inoculated and coinfected 728 vs

Supplemental Table 2 provides statistically significant GO terms for each comparison (infected 731 or coinfected vs. mock-inoculated and coinfected vs

Supplemental Table 3 provides a summary of results from negative binomial regression analyses

Weight loss of mice used in the RNA-seq and flow cytometry experiments. Mice were 737 inoculated intranasally with saline (mock) or RV on day -2 and PR8 or PVM on day 0. Weight 738 was recorded daily for all mice until the pre-determined time points. Days -2 through 2, N=15 per 739 group

Read coverage of individual viral genes. The proportion of reads mapping to each viral

Heatmap of mock/PVM vs. RV/PVM unique genes. Expression of genes that are that are significantly different between mock/PVM and RV/PVM infected mice that are also 756 significant between mock/PR8 and RV/PR8 infected mice. Colors represent Z-scores for

Left lungs were processed for 766 flow cytometry staining with antibodies against CD11b, Ly6G, CD64, and Siglec F. Total cell 767 counts for all samples and representative plots showing the gating strategy to identify neutrophils, 768 alveolar macrophages

Left lungs were processed for flow 771 cytometry staining with antibodies against CD3, CD4, and CD8 to identify total CD4+ and CD8+ either mock-inoculated (mock/PVM) or inoculated intranasally with 7.6 x 10 6 TCID 50 units 778 of RV two days before (RV/PVM), simultaneously with (RV+PVM)

TCID 50 units of PVM. Mice were monitored daily for (A) mortality and (B) weight loss

Statistical significance compared to mock/PVM was determined by (A) Log-rank Mantel-Cox test 781 and (B) student's t-test corrected for multiple comparisons using the Holm-Sidak method

The largest distances in single vs. coinfected groups are 792 mock/PVM vs. RV/PVM on day 4 and mock/PR8 vs. RV/PR8 in the coinfected compared to the single-virus infected mice are colored green. Down-795 regulated genes are colored purple. (C) Numbers of DEGs in all pairwise comparisons. The 796 number of genes upregulated in the infected

Viral gene expression in single virus and coinfected mouse lungs. For each group, the 801 three replicates are shown with box plots indicating the quantile values of percent non-mouse reads

Fig 6. Expression of MSigDB Hallmark Interferon Alpha Response and Inflammatory

Heatmaps of Hallmark Interferon Alpha Response genes showing the relative 812 expression (Z-scores) of genes for the (A) PR8 or (B) PVM coinfection RNA-seq timecourse

Z-scores) 814 of genes for the (C) PR8 or (D) PVM coinfection RNA-seq timecourse. All heatmaps represent clustering. The colors (blue < white < red) represent the Z-score and a more intense 817 color indicates a lower (blue) or higher (red) relative expression of that gene in that condition

of neutrophil (I, K) and monocyte/macrophage (J, L) specific chemokine genes from the RNA-seq 828